Purchase Order 75N94023P00558
- Not listed
- This is a $116,500.00 firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. The contract is for the provision of various research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and investigational drugs. There is no set-aside...
- This is a $117,000.00 firm fixed price purchase order awarded to Frontage Laboratories, Inc. by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The contract is for Frontage Laboratories to provide a range of preclinical research services, including pharmacokinetic testing, in vivo studies, compound synthesis, and fertility assessments, to support the development of new therapies and...
- This is a $93,800 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for pharmacokinetic testing and research services related to the compound MTS-IV-39. Frontage Laboratories has a history of providing a range of research services to NIDDK and the National Institutes of Health, including compound synthesis, in vivo studies,...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to Frontage Laboratories, Inc. for $126,850.00. The contract is for research services related to the "Blood Stability and Metabolism of MTS-IV-39 Analogs." This work supports NIDDK's research program and was not set aside for any specific business category. Frontage Laboratories is a full-service contract...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $88,000 firm fixed price purchase order to Frontage Laboratories, Inc., a full-service contract research organization, to provide specialized pharmacokinetic and metabolism research services. The contract supports NIDDK's efforts to advance the testing of a new class of antiviral molecules by conducting blood stability studies, rat and mouse pharmacokinetic studies, and in vitro hepatocyte metabolism studies...
- This is a $19,000 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Frontage Laboratories, Inc., a full-service contract research organization (CRO). The contract is for the synthesis of SAMT-247 and an analog compound. Frontage Laboratories has previously supported NIDDK and the National Center for Advancing Translational Sciences through various federal contracts, providing services such as pharmacokinetic testing, in...
- This is a $20,960 fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the JAI Research Foundation, a non-profit organization. The contract is for solubility, stability, and toxicology studies to advance novel drug candidates developed by the NIDDK into clinical trials. This contract was awarded on September 25, 2020 and has a completion date of September 24, 2021. The contract stems from a small...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $18,000 purchase order to Frontage Laboratories, Inc. for blood stability studies. Frontage Laboratories, the prime contractor, will perform the studies at its facility located in Exton, Pennsylvania over a two-month period concluding in early October 2018. The contract is a firm fixed price award to support the funding agency's research into...
- This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $113,400 contract is part of the NIH Bioanalysis Testing Services 2015-2020 IDIQ (Indefinite Delivery/Indefinite Quantity) vehicle. The work involves conducting pharmacokinetic assessments, toxicity studies, and ion channel testing services to support drug discovery and development efforts, including evaluating...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $27,400.00, is for lab testing services and was set aside for a small business, Enamine US Inc. Based in New Jersey, Enamine US Inc. is a for-profit organization that specializes in chemical research and pharmaceutical services, and has a history of delivering...
This firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Valued at $155,100, the contract calls for Frontage Laboratories Inc. to provide services in support of compound 21 testing and in vivo pharmacokinetics studies. Specifically, the prime contractor will scale up production of compound 21 to deliver 10 grams to NIDDK for further testing, and conduct pharmacokinetics studies of the compound in rats and mice, examining metabolism. This work directly supports the objective stated in the original solicitation to advance testing of compound 21 as a potential new HIV treatment. Results will contribute to an investigational new drug application to the U.S. Food and Drug Administration. The contract is to be performed in Exton, Pennsylvania over a six-month period concluding in January 2024.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Acquisition of Services Related to Compound 21 and In Vivo Pharmacokinetics Studies | NICHD-23-231 | Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development | Pre-Solicitation 1/1 | 6/28/23, 6:18 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $155.1k | 7/25/23 |